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Abstract
Cesarean scar defect often causes postmenstrual abnormal uterine bleeding, dysmenor-
rhea, chronic pelvic pain, and infertility, which are collectively known as cesarean scar syn-
drome (CSS). Several studies have reported that hysteroscopic surgery can restore fertility
in women with CSS. The study aimed to identify factors that influence subsequent preg-
nancy following hysteroscopic surgery. Therefore, we studied 38 women with secondary
infertility due to CSS who underwent hysteroscopic surgery at Shiga University of Medical
Hospital between July 2014 and July 2019. Our hysteroscopic procedure included inferior
edge resection and superficial cauterization of the cesarean scar defect under laparoscopic
guidance. Patients were followed up for 3 to 40 months after surgery. Surgery was success-
ful in all cases and no complications were observed. Twenty-seven patients (71%) became
pregnant (pregnant group), while 11 (29%) did not (non-pregnant group). Baseline charac-
teristics of age, body mass index, gravidity, parity, previous cesarean section, presence of
endometriosis, retroflex uterus, and preoperative residual myometrial thickness were not
significantly different between the groups. However, the median residual myometrium thick-
ness was significantly higher after surgery than before surgery in the pregnant group (1.9
[1.1–3.6] vs 4.9 [3.4–6.6] mm, P<0.0001), whereas this difference was not significant in
the non-pregnant group. Of those who became pregnant, 85% conceived within 2 years of
surgery. Although three pregnancies resulted in abortion and one is ongoing at the time
of writing, 23 pregnancies resulted in healthy babies at 35–38 gestational weeks by sched-
uled cesarean sections with no obstetrical complications due to hysteroscopic surgery. The
average birth weight was 3,076 g. Our findings support that hysteroscopic surgery is a safe
and effective treatment for secondary infertility due to CSS. The thickness of the residual
myometrium may be a key factor that influences subsequent pregnancy in women with
CSS.
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Introduction
The rate of cesarean section is increasing worldwide. In Japan, it reached 18.5% in 2013, which
is nearly a two-fold increase in the past two decades [1]. With the increase in cesarean sections,
the incidence of cesarean section scar-related complications has also risen. Cesarean section
often results in a cesarean scar defect (CSD), also known as isthmocele, which reportedly
occurs in 24–84% of women after cesarean section [2,3]. Although there is still no clear univer-
sal definition of this term, it is commonly used in the literature to indicate a myometrial dis-
continuity or a hypoechoic region in the lower anterior uterine wall via transvaginal
ultrasound detection [3,4]. CSD can cause secondary infertility with postmenstrual abnormal
uterine bleeding, dysmenorrhea, and chronic pelvic pain [5]. These symptoms are collectively
known as cesarean scar syndrome (CSS) [6]. We have previously investigated the management
of secondary infertility for patients with CSS in Japan and found that surgical treatment,
including laparotomy, laparoscopy, and hysteroscopy, was effective for restoring fertility in
such patients [5]. Although there is an ongoing debate regarding the best surgical approach,
hysteroscopic treatment is considered less invasive than other approaches and may be an effec-
tive treatment option for restoring fertility in women with CSS [7–9]. However, the predictors
of subsequent reproductive outcomes following hysteroscopic treatment are still not clear.
Therefore, we aimed to investigate the reproductive and obstetric outcomes and the interval
between treatment and conception following hysteroscopic procedures.
Materials and methods
Study population and recruitment
The participants of this retrospective study were patients who underwent hysteroscopic sur-
gery for CSS between July 2014 and July 2019 at the Shiga University of Medical Science. The
inclusion criteria were women diagnosed with CSS. CSS was diagnosed by detecting both CSD
and the presence of abnormal uterine bleeding or liquid pooling on transvaginal ultrasonogra-
phy. Exclusion criteria were women who were not intending to conceive. All patients under-
went cancer screenings to exclude abnormal cervical cytology. Subsequent pregnancy was
confirmed by the presence of a gestational sac in the uterus. Participants were categorized into
two groups, pregnant or non-pregnant, according to the outcome of conception after surgery.
Written informed consent was obtained from all patients prior to surgery. All data were fully
anonymized before we accessed them, and patients’ medical records were accessed between
June 2020 and July 2020. This study was approved by the Ethics Committee at Shiga University
of Medical Science (approval number; R2020-039) and performed at the Shiga University of
Medical Science.
Surgical procedures
We performed hysteroscopic surgery as previously described [10]. Briefly, hysteroscopic sur-
gery was performed using a rigid 30˚ hysteroscope (4 mm telescope) and working elements
(#27050, KARL STORZ, Germany) connected to a video camera and monitor (Olympus,
Tokyo, Japan). Diagnostic laparoscopy was performed simultaneously to monitor accidental
perforation at the site of the CSD and to treat other causes of infertility, such as endometriosis,
because the aim of this operation was to restore fertility. Cervical dilation was carried out the
day before surgery. First, hysteroscopic resection of the CSD inferior edge was performed
using a cutting loop electrode to enable visualization of the diverticulum. Next, the entire CSD
was cauterized using a ball electrode (Fig 1 and S1 File). Patients were discharged 2 to 3 days
after surgery.
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Data collection
Baseline characteristics included age, body mass index, gravidity, parity, previous cesarean sec-
tion(s), frequency of endometriosis, and retroflex uterus. Residual myometrial thickness
(RMT) was measured by magnetic resonance imaging (MRI) before and 2 months after sur-
gery using a 1.5-T instrument (SIGNA HDxt; GE Healthcare Waukesha, WI, USA) with a car-
diac coil. The settings for MRI were applied as described previously [10]. All measurements
were conducted by one senior radiologist using a high-resolution monitor. The interval from
operation to conception was evaluated based on patient medical records. For patients who did
not continue to attend our hospital, we confirmed their current situation via a medical infor-
mation provision form from their referral hospital or by telephone.
Statistical analysis
All data were analyzed using GraphPad Prism ver.7 (GraphPad Software, Inc., San Diego, CA,
USA). The D’Agostino-Pearson test was used to evaluate data distribution. Normally distrib-
uted data are expressed as mean ± standard deviation. Data with a non-normal distribution
are presented as median (interquartile range). Categorical data were compared by Fisher’s
exact test. Comparisons between the pregnant and non-pregnant participants were carried out
using an unpaired two-tailed t-test or the Mann-Whitney U test for parametric and non-
Fig 1. Intraoperative images of the hysteroscopic surgery procedure. (A) Abnormal hypervascularity is observed in
the cesarean scar defect. (B) Cutting of the inferior edge of the cesarean scar defect using a cutting loop electrode. (C)
Cauterization of all areas including the abnormal vasculature in the cesarean scar defect. (D) Appearance after
cauterization using a ball electrode.
https://doi.org/10.1371/journal.pone.0243421.g001
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parametric data, respectively. The cumulative pregnancy rate was evaluated using the Kaplan-
Meier method. Statistical significance was defined as P < 0.05 in all cases.
Results
Thirty-eight patients who met the inclusion criteria during the study period were included in
the analysis. No complications were experienced by any patients. Twenty-seven patients (71%)
became pregnant (pregnant group) and 11 patients (29%) did not become pregnant (non-
pregnant group) (S1 Table). Baseline characteristics did not significantly differ between the
two groups (Table 1). Two cases did not undergo laparoscopy for individual reasons; therefore,
information on endometriosis was not available at the time of hysteroscopic surgery. Endome-
triosis was detected in 19 patients (52.8%) during hysteroscopic surgery. A blueberry spot was
detected in one case on the surface of the CSD (S1 Fig).
Pre- and postoperative RMTs were measured in 34 patients (postoperative measurement
was not carried out in four cases due to individual reasons). The median pre- and postopera-
tive RMT measurements were 2.0 (1.1–3.7) mm and 4.4 (2.5–6.0) mm, respectively
(P< 0.0001) (Fig 2A). Considering the pregnant group alone, the postoperative RMT was sig-
nificantly higher than the preoperative RMT (1.9 [1.1–3.6] mm vs 4.9 [3.4–6.6] mm,
P< 0.0001); however, the difference was not significant in the non-pregnant group (2.1 [0.8–
3.9] mm vs 2.3 [2.1–4.4] mm) (Fig 2B and 2C). A significant difference was observed in post-
operative RMT between the pregnant and non-pregnant groups (4.9 [3.4–6.6] mm vs 2.3 [2.1–
4.4] mm, respectively; P = 0.02).
After hysteroscopy, 17 patients became pregnant within 1 year and six became pregnant
during the following year. The cumulative pregnancy rate is illustrated in Fig 3. Pregnancy is
ongoing in one case and three cases resulted in spontaneous abortions. The mean birth weight
among all the patients who gave birth was 3,076 ± 435 g. One patient underwent a scheduled
cesarean section at 35 gestational weeks due to placenta previa. All other deliveries were sched-
uled cesarean sections following the individual policies of the obstetric hospitals; four delivered
at 36 gestational weeks, eight delivered at 37 gestational weeks, and 10 delivered at 38 gesta-
tional weeks. No severe obstetrical complications, such as uterine rupture, occurred up to the
day of cesarean section in any case.
Discussion
To the best of our knowledge, this is the first report to evaluate the changes in residual myome-
trium thickness after surgery in relation to subsequent reproductive outcomes. The present
Table 1. Comparison of patients and clinical data.
Pregnancy (n = 27) Non-pregnancy (n = 11) P
Age, yrs 35.6±3.4 37.0±4.2 n.s.
BMI 22.2±3.7 21.5±3.1 n.s.
Gravidity 1 (1–2) 2 (1–2) n.s.
Parity 1 (1–1) 1 (1–2) n.s.
Previous CS 1 (1–1) 1 (1–2) n.s.
Endometriosis (%) 14 (52)� 5 (45) n.s.
Retroflexion(%) 14(52) 3(27) n.s.
RMT preoperatively (mm) 2.3(1.3–3.8) 2.1 (0.8–3.9) n.s.
BMI: Body mass index, CS: cesarean section, RMT: Residual myometrium thickness, Data are median (quartiles)
�Two patients did not undergo laparoscopy.
https://doi.org/10.1371/journal.pone.0243421.t001
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retrospective observational study demonstrates the safety and efficacy of hysteroscopic surgery
for treating secondary infertility caused by CSS. Our results found that the pregnancy rate was
high after hysteroscopic surgery and the postoperative thickening of the residual myometrium
was associated with successful reproductive outcomes.
Fig 2. Graphical representations of the residual myometrial thickness before and after hysteroscopic surgery. The pre- and postoperative residual
myometrial thicknesses of (A) the entire study population, (B) pregnant women, and (C) non-pregnant women. Significant differences between pre- and
postoperative measurements were detected among the entire cohort and pregnant women. ����P< 0.0001.
https://doi.org/10.1371/journal.pone.0243421.g002
Fig 3. Cumulative pregnancy rate after hysteroscopic surgery in women with infertility due to cesarean scar
syndrome (n = 38).
https://doi.org/10.1371/journal.pone.0243421.g003
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Hysteroscopic surgery in the context of CSS is mainly performed to treat abnormal uterine
bleeding [11–13]; however, many recent reports have demonstrated the effectiveness of this
technique for restoring fertility [8,10,14–17]. In women with CSS, infertility may arise due to
abnormal uterine bleeding originating from a small hemorrhage in the CSD that interferes
with implantation [8,14]. Previous reports performed hysteroscopic resection of both the supe-
rior and inferior edges of the CSD, whereas the surgical procedure used in this study resected
only the inferior edge of the CSD; therefore, the present study is valuable to the field as we pro-
vide further validation of the effectiveness of hysteroscopic surgery for the treatment of infer-
tility. Furthermore, we demonstrated the safety of our hysteroscopic surgery method, as no
surgery-related complications, such as perforation, occurred, even in cases with a thin residual
myometrium, and no obstetrical complications, such as uterine rupture, occurred during preg-
nancy. The first prospective study on the effectiveness of hysteroscopic surgery was carried out
by Gubbini et al. [16] who reported that among 41 patients, no complications were noted dur-
ing the perinatal period after hysteroscopic surgery. Thus, the minimally invasive technique of
hysteroscopy is a safe treatment, both intraoperatively and postoperatively, in regard to subse-
quent pregnancy.
Regarding the main reason of infertility in participants, 68% of women became pregnant
spontaneously in their prior pregnancy (S1 Table). However, they became infertile after cesar-
ean section regardless of whether various treatments, including IVF, were conducted. On the
other hand, 32% of women became pregnant by assisted reproductive technology (ART) in
their prior pregnancy. Therefore, ART was performed after cesarean section during the long
period; however, these patients could not become pregnant. Furthermore, abnormal uterine
bleeding or liquid pooling in the CSD or uterine cavity was an obvious abnormal finding asso-
ciated with infertility. Taken together, we speculate that the infertility observed in these partici-
pants was caused by CSS. However, we considered that CSS may not have been the sole cause
of infertility in these patients, because around half of the patients also had endometriosis.
Although the study population had CSS-related infertility, we treated endometriosis and
the area of the CSD because endometriosis is a well-known cause of infertility [18,19]. Interest-
ingly, laparoscopic investigation revealed that around half of the patients in the present study
had endometriosis in the peritoneal cavity. In the general population, the frequency of endo-
metriosis is around 10%; however, there was a higher rate of endometriosis in present study
[18]. Several reports on the presence of endometriosis in patients with CSD [17,20] are in
agreement with our detection of the blueberry spot in one patient with CSD, supporting the
potential association between CSS and endometriosis. In addition, the interval between sur-
gery and pregnancy was within 2 years for most patients in the present study, and endometri-
osis usually recurs within 2 years of surgery [18,19]. Therefore, we suggest that this surgery
may provide a sufficient “endometriosis-free” window to enable conception.
A laparoscopic retractor was sometimes useful during cauterization of the CSD with a ball
electrode because it can be difficult to access the inner wall of the diverticulum due to large
defects, especially when they are located on the lateral side. In the present study, the uterus was
moved to the left side using laparoscopic forceps when defects were located on the right lateral
side, and the side of the CSD was gently pressed from the outside of the uterus using Endo Pea-
nut1 (Medtronic, MN, USA). Therefore, hysteroscopic treatment with laparoscopy is a safe
option for the treatment of infertility; specifically, laparoscopy can be beneficial during hyster-
oscopic surgery, especially in cases with large defects.
We have previously reported that RMT increases following our procedure of hysteroscopy
[10], which is supported by the present study and a previous study [21]. Both reports used a
roller ball electrode to electrocauterize the bottom of the diverticulum, with no resection of the
bottom in the diverticulum. In contrast, another study that resected CSD scar tissue did not
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identify changes in RMT after hysteroscopic resection [17]. Therefore, different methods of
hysteroscopy may lead to varying results. Although a consensus statement from the global con-
gress on hysteroscopy scientific committee appealed that the laparoscopic approach should be
favored if the myometrial thickness is less than 3 mm, Gubbini et al. proposed that it could still
be disputable to consider the indication of hysteroscopic surgery [22,23]. The mode of delivery
following resectoscopic surgery in this study was planned cesarean section in all cases.
Although cesarean section can result in several complications for the mother and baby, we
considered the mode of delivery was better than trial of labor after cesarean section because
there was no evidence of the risk of uterine rupture following hysteroscopic surgery for isth-
mocele [24,25].
This study has several limitations that should be considered. First, endometriosis treatment
affected subsequent conception. However, the presence of endometriosis before surgery did
not influence the rate of conception after surgery. We also suspect that endometriosis treat-
ment did not affect conception following hysteroscopic surgery. Second, although there was a
significant change in postoperative RMT in the pregnant group, this study could not reveal the
exact mechanism of thickening. We consider that the treatment of inflammatory tissue in the
CSD might promote the regeneration of fibrotic tissue or elimination of pressure as liquid
pools in the defect, resulting in the thickening of the residual myometrium. Liquid pools in the
CSD might affect RMT thinning via pressure. We consider that improving the environment in
the uterine cavity might contribute to successful conception. In the non-pregnant group, myo-
metrial regeneration in the CSD might have been inhibited due to insufficient treatment. It is
evident that there is room for further improvement in our procedure to increase the pregnancy
rate after hysteroscopic surgery. Third, this study included a small patient cohort and was a
short-term study. Therefore, further investigation of a larger patient population is needed to
verify the safety and efficacy of this procedure for infertile women with CSS. Fourth, due to
our study’s non-randomized design, the contributions of hysteroscopic surgery to subsequent
pregnancy were controversial in women who became pregnant after the long period following
hysteroscopic surgery.
In conclusion, hysteroscopic surgery is a safe, minimally invasive treatment for the restoration
of fertility in women with CSS. Our findings suggest that the thickening of the residual myome-
trium following hysteroscopic surgery may influence subsequent reproductive outcomes.
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